source
- Lilly advances retatrutide toward sleep-apnea marketEli Lilly is moving its triple-agonist drug retatrutide closer to a potential launch for sleep-apnea. The company, which expects to introduce the drug for obesity next year, is now gathering data i…
- STAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approvedAfter a quarter century of work, the German biotech Immatics is facing a pivotal moment as it awaits Phase 3 results for its lead candidate in melanoma.STAT · 41m ago↗ source
- Opinion: How knocking on doors can help beat measles — again“As measles outbreaks spread in the U.S., it may be time to learn how other countries get their outbreaks under control,” writes Raj Panjabi.